Defining progression independent of relapse activity (PIRA) in adult patients with relapsing multiple sclerosis: A systematic review✰

Multiple sclerosis: role of meningeal lymphoid aggregates in progression independent of relapse activity

(2023) Richard M. Ransohoff   TRENDS IN IMMUNOLOGY

How patients with multiple sclerosis acquire disability

(2022) Fred D. Lublin et al.   BRAIN

Assessment of Disability Progression Independent of Relapse and Brain MRI Activity in Patients with Multiple Sclerosis in Poland

(2021) Katarzyna Kapica-Topczewska et al.   Journal of Clinical Medicine

NfL predicts relapse-free progression in a longitudinal multiple sclerosis cohort study

(2021) Timo Uphaus et al.   EBioMedicine

Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline

(2020) Mhairi Campbell et al.   BMJ-British Medical Journal

Ofatumumab versus Teriflunomide in Multiple Sclerosis

(2020) Stephen L. Hauser et al.   NEW ENGLAND JOURNAL OF MEDICINE

Contribution of Relapse-Independent Progression vs Relapse-Associated Worsening to Overall Confirmed Disability Accumulation in Typical Relapsing Multiple Sclerosis in a Pooled Analysis of 2 Randomized Clinical Trials

(2020) Ludwig Kappos et al.   JAMA Neurology

Brain TSPO-PET predicts later disease progression independent of relapses in multiple sclerosis

(2020) Marcus Sucksdorff et al.   BRAIN

Silent Progression in Disease Activity-Free Relapsing Multiple Sclerosis

(2019) et al.   ANNALS OF NEUROLOGY

Worsening of disability caused by relapses in multiple sclerosis: A different approach

(2019) Nils Koch-Henriksen et al.   Multiple Sclerosis and Related Disorders

Differentiating societal costs of disability worsening in multiple sclerosis

(2019) Nils-Henning Ness et al.   JOURNAL OF NEUROLOGY

Defining secondary progressive multiple sclerosis

(2016) Johannes Lorscheider et al.   BRAIN